Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer. [electronic resource]
- Cancer treatment reports
- 2107-9 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0361-5960
Bone Marrow--drug effects Cisplatin--administration & dosage Drug Evaluation Hearing--drug effects Humans Kidney--drug effects Lung Neoplasms--drug therapy Vomiting--chemically induced